Substituted indazole derivatives active as kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9616059
SERIAL NO

14971372

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Substituted indazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a deregulated protein kinase activity, like cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NERVIANO MEDICAL SCIENCES S R L20014 NERVIANO (MI)

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lombardi, Borgia Andrea Paullo, IT 24 247
Marchionni, Chiara Milan, IT 22 351
Menichincheri, Maria Milan, IT 45 420
Nesi, Marcella Saronno, IT 44 329
Orsini, Paolo Legnano, IT 47 763
Panzeri, Achille Merate, IT 41 320
Perrone, Ettore Boffalora Sopra Ticino, IT 49 353
Vanotti, Ermes Milan, IT 40 296

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 11, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00